Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer
- 31 March 1996
- Vol. 119 (3) , 333-339
- https://doi.org/10.1016/s0039-6060(96)80120-6
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancerThe Lancet, 1992
- A model system for tumor angiogenesis: Involvement of transforming growth factor-α in tube formation of human microvascular endothelial cells induced by esophageal cancer cellsBiochemical and Biophysical Research Communications, 1992
- MCF7 mammary cancer cells respond to bFGF and internalize it following its release from extracellular matrix: A permissive role of cathepsin DExperimental Cell Research, 1991
- Expression of transforming growth factor alpha (TGFα) in breast cancerAnnals of Oncology, 1991
- Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast CarcinomaNew England Journal of Medicine, 1991
- Cancer metastasis and angiogenesis: An imbalance of positive and negative regulationCell, 1991
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990
- Metastasis and AngiogenesisActa Oncologica, 1990
- Angiogenic FactorsScience, 1987